Global In Situ Hybridization Technology Services 麻豆原创 Research Report 2024

Publication ID:

PB509240288

Publication Date:

September 19, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

In situ hybridization is a molecular biology-based technology service that uses specific nucleic acid probes to hybridize with nucleic acids in cells or tissues to achieve precise quantitative positioning of specific DNA or RNA sequences. This technology combines the principles of molecular biology, histochemistry and cytology, and determines the location and quantity of the target sequence by observing the probe signal under a microscope.
The global In Situ Hybridization Technology Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for In Situ Hybridization Technology Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for In Situ Hybridization Technology Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for In Situ Hybridization Technology Services in Scientific Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of In Situ Hybridization Technology Services include Creative BioMart, Agilent Technologies, Enzo Life Sciences, Inc., OGT, Precision for Medicine, VitaScientific, Advanced Cell Diagnostics, Creative Diagnostics, Genemed CISH, Zytomed Systems GmbH, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In Situ Hybridization Technology Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Situ Hybridization Technology Services.
The In Situ Hybridization Technology Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Situ Hybridization Technology Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Situ Hybridization Technology Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Creative BioMart
Agilent Technologies
Enzo Life Sciences, Inc.
OGT
Precision for Medicine
VitaScientific
Advanced Cell Diagnostics
Creative Diagnostics
Genemed CISH
Zytomed Systems GmbH
CLOUD-CLONE CORP.
CytoCell myProbes
Charles River
Bio-Techne
Daicel Arbor Biosciences
Segment by Type
DNA in Situ Hybridization
RNA in Situ Hybridization
Segment by Application
Scientific Research
Agricultural
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Situ Hybridization Technology Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global In Situ Hybridization Technology Services 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA in Situ Hybridization
1.2.3 RNA in Situ Hybridization
1.3 麻豆原创 by Application
1.3.1 Global In Situ Hybridization Technology Services 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Scientific Research
1.3.3 Agricultural
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Situ Hybridization Technology Services 麻豆原创 Perspective (2019-2030)
2.2 Global In Situ Hybridization Technology Services Growth Trends by Region
2.2.1 Global In Situ Hybridization Technology Services 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Situ Hybridization Technology Services Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 In Situ Hybridization Technology Services Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 In Situ Hybridization Technology Services 麻豆原创 Dynamics
2.3.1 In Situ Hybridization Technology Services Industry Trends
2.3.2 In Situ Hybridization Technology Services 麻豆原创 Drivers
2.3.3 In Situ Hybridization Technology Services 麻豆原创 Challenges
2.3.4 In Situ Hybridization Technology Services 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Situ Hybridization Technology Services Players by Revenue
3.1.1 Global Top In Situ Hybridization Technology Services Players by Revenue (2019-2024)
3.1.2 Global In Situ Hybridization Technology Services Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global In Situ Hybridization Technology Services 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Situ Hybridization Technology Services Revenue
3.4 Global In Situ Hybridization Technology Services 麻豆原创 Concentration Ratio
3.4.1 Global In Situ Hybridization Technology Services 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Situ Hybridization Technology Services Revenue in 2023
3.5 Global Key Players of In Situ Hybridization Technology Services Head office and Area Served
3.6 Global Key Players of In Situ Hybridization Technology Services, Product and Application
3.7 Global Key Players of In Situ Hybridization Technology Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Situ Hybridization Technology Services Breakdown Data by Type
4.1 Global In Situ Hybridization Technology Services Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global In Situ Hybridization Technology Services Forecasted 麻豆原创 Size by Type (2025-2030)
5 In Situ Hybridization Technology Services Breakdown Data by Application
5.1 Global In Situ Hybridization Technology Services Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global In Situ Hybridization Technology Services Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America In Situ Hybridization Technology Services 麻豆原创 Size (2019-2030)
6.2 North America In Situ Hybridization Technology Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In Situ Hybridization Technology Services 麻豆原创 Size by Country (2019-2024)
6.4 North America In Situ Hybridization Technology Services 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Situ Hybridization Technology Services 麻豆原创 Size (2019-2030)
7.2 Europe In Situ Hybridization Technology Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In Situ Hybridization Technology Services 麻豆原创 Size by Country (2019-2024)
7.4 Europe In Situ Hybridization Technology Services 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Situ Hybridization Technology Services 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific In Situ Hybridization Technology Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In Situ Hybridization Technology Services 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific In Situ Hybridization Technology Services 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Situ Hybridization Technology Services 麻豆原创 Size (2019-2030)
9.2 Latin America In Situ Hybridization Technology Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In Situ Hybridization Technology Services 麻豆原创 Size by Country (2019-2024)
9.4 Latin America In Situ Hybridization Technology Services 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Situ Hybridization Technology Services 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa In Situ Hybridization Technology Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In Situ Hybridization Technology Services 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa In Situ Hybridization Technology Services 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative BioMart
11.1.1 Creative BioMart Company Details
11.1.2 Creative BioMart Business Overview
11.1.3 Creative BioMart In Situ Hybridization Technology Services Introduction
11.1.4 Creative BioMart Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.1.5 Creative BioMart Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies In Situ Hybridization Technology Services Introduction
11.2.4 Agilent Technologies Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.2.5 Agilent Technologies Recent Development
11.3 Enzo Life Sciences, Inc.
11.3.1 Enzo Life Sciences, Inc. Company Details
11.3.2 Enzo Life Sciences, Inc. Business Overview
11.3.3 Enzo Life Sciences, Inc. In Situ Hybridization Technology Services Introduction
11.3.4 Enzo Life Sciences, Inc. Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.3.5 Enzo Life Sciences, Inc. Recent Development
11.4 OGT
11.4.1 OGT Company Details
11.4.2 OGT Business Overview
11.4.3 OGT In Situ Hybridization Technology Services Introduction
11.4.4 OGT Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.4.5 OGT Recent Development
11.5 Precision for Medicine
11.5.1 Precision for Medicine Company Details
11.5.2 Precision for Medicine Business Overview
11.5.3 Precision for Medicine In Situ Hybridization Technology Services Introduction
11.5.4 Precision for Medicine Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.5.5 Precision for Medicine Recent Development
11.6 VitaScientific
11.6.1 VitaScientific Company Details
11.6.2 VitaScientific Business Overview
11.6.3 VitaScientific In Situ Hybridization Technology Services Introduction
11.6.4 VitaScientific Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.6.5 VitaScientific Recent Development
11.7 Advanced Cell Diagnostics
11.7.1 Advanced Cell Diagnostics Company Details
11.7.2 Advanced Cell Diagnostics Business Overview
11.7.3 Advanced Cell Diagnostics In Situ Hybridization Technology Services Introduction
11.7.4 Advanced Cell Diagnostics Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.7.5 Advanced Cell Diagnostics Recent Development
11.8 Creative Diagnostics
11.8.1 Creative Diagnostics Company Details
11.8.2 Creative Diagnostics Business Overview
11.8.3 Creative Diagnostics In Situ Hybridization Technology Services Introduction
11.8.4 Creative Diagnostics Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.8.5 Creative Diagnostics Recent Development
11.9 Genemed CISH
11.9.1 Genemed CISH Company Details
11.9.2 Genemed CISH Business Overview
11.9.3 Genemed CISH In Situ Hybridization Technology Services Introduction
11.9.4 Genemed CISH Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.9.5 Genemed CISH Recent Development
11.10 Zytomed Systems GmbH
11.10.1 Zytomed Systems GmbH Company Details
11.10.2 Zytomed Systems GmbH Business Overview
11.10.3 Zytomed Systems GmbH In Situ Hybridization Technology Services Introduction
11.10.4 Zytomed Systems GmbH Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.10.5 Zytomed Systems GmbH Recent Development
11.11 CLOUD-CLONE CORP.
11.11.1 CLOUD-CLONE CORP. Company Details
11.11.2 CLOUD-CLONE CORP. Business Overview
11.11.3 CLOUD-CLONE CORP. In Situ Hybridization Technology Services Introduction
11.11.4 CLOUD-CLONE CORP. Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.11.5 CLOUD-CLONE CORP. Recent Development
11.12 CytoCell myProbes
11.12.1 CytoCell myProbes Company Details
11.12.2 CytoCell myProbes Business Overview
11.12.3 CytoCell myProbes In Situ Hybridization Technology Services Introduction
11.12.4 CytoCell myProbes Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.12.5 CytoCell myProbes Recent Development
11.13 Charles River
11.13.1 Charles River Company Details
11.13.2 Charles River Business Overview
11.13.3 Charles River In Situ Hybridization Technology Services Introduction
11.13.4 Charles River Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.13.5 Charles River Recent Development
11.14 Bio-Techne
11.14.1 Bio-Techne Company Details
11.14.2 Bio-Techne Business Overview
11.14.3 Bio-Techne In Situ Hybridization Technology Services Introduction
11.14.4 Bio-Techne Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.14.5 Bio-Techne Recent Development
11.15 Daicel Arbor Biosciences
11.15.1 Daicel Arbor Biosciences Company Details
11.15.2 Daicel Arbor Biosciences Business Overview
11.15.3 Daicel Arbor Biosciences In Situ Hybridization Technology Services Introduction
11.15.4 Daicel Arbor Biosciences Revenue in In Situ Hybridization Technology Services Business (2019-2024)
11.15.5 Daicel Arbor Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Creative BioMart
Agilent Technologies
Enzo Life Sciences, Inc.
OGT
Precision for Medicine
VitaScientific
Advanced Cell Diagnostics
Creative Diagnostics
Genemed CISH
Zytomed Systems GmbH
CLOUD-CLONE CORP.
CytoCell myProbes
Charles River
Bio-Techne
Daicel Arbor Biosciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.